Design and Development of Intracellular Paired Agent Imaging Molecules for Quantitative Assessment of Cancer Drug Target Availability

Explore the design and development of intracellular paired agent imaging (iPAI) molecules for quantitative assessment of cancer drug target availability in live cells and tissues in this 22-minute presentation by William Bisson Ph.D. from OHSU Knight Cancer Institute. Delivered at MolSoft's UGM 2023 on May 18th, 2023, the talk delves into innovative approaches for evaluating cancer drug targets using advanced molecular imaging techniques. Gain insights into the latest advancements in cancer research and drug development, focusing on the application of iPAI molecules in live cell and tissue analysis. For further information on this cutting-edge topic, visit www.molsoft.com or contact [email protected].

Design and Dev. of iPAI molecules for quantitative assessment of cancer drug target availability.